RTI Surgical received FDA 510(k) clearance to market the Dynamic Active Compression (DAC) Plate for stabilization and fixation of small foot bones. This represents the company’s first 510(k) Clearance since the company became an independent player with its purchase by Montagu Private Equity.
DAC combines the rigid stability of a plate with Nitinol’s ability to provide continuous compression and ensure apposition of bony surfaces during healing.
“The DAC plate is a prime example of how we are able to leverage our core capabilities to enter a new market. Our trauma experience was crucial in creating the first hardware product we specifically designed for lower extremities in the foot and ankle space. We look forward to continuing to bring new technologies to the market to address unmet needs and help patients,” said Jimmy Blanchard, Vice President of Sales.
RTI Surgical received FDA 510(k) clearance to market the Dynamic Active Compression (DAC) Plate for stabilization and fixation of small foot bones. This represents the company's first 510(k) Clearance since the company became an independent player with its purchase by Montagu Private Equity.
DAC combines the rigid stability of a plate...
RTI Surgical received FDA 510(k) clearance to market the Dynamic Active Compression (DAC) Plate for stabilization and fixation of small foot bones. This represents the company’s first 510(k) Clearance since the company became an independent player with its purchase by Montagu Private Equity.
DAC combines the rigid stability of a plate with Nitinol’s ability to provide continuous compression and ensure apposition of bony surfaces during healing.
“The DAC plate is a prime example of how we are able to leverage our core capabilities to enter a new market. Our trauma experience was crucial in creating the first hardware product we specifically designed for lower extremities in the foot and ankle space. We look forward to continuing to bring new technologies to the market to address unmet needs and help patients,” said Jimmy Blanchard, Vice President of Sales.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
